Reduction of arthritis severity in protease-activated receptor-deficient mice.
about
Functional role of kallikrein 6 in regulating immune cell survival.Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A.mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin.Functional responses of bone cells to thrombin.Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer.Novel aspects of fibrin(ogen) fragments during inflammation.Platelets and autoimmunity.Protease-activated receptor 4: a critical participator in inflammatory response.Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation.Activation of PAR(2) receptors sensitizes primary afferents and causes leukocyte rolling and adherence in the rat knee joint.Silencing of protease-activated receptors attenuates synovitis and cartilage damage following a joint bleed in haemophilic mice.Detection of Subclinical Arthritis in Mice by a Thrombin Receptor-Derived Imaging Agent.Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms.
P2860
Q33862447-A6A4BFD5-CA24-4DF4-9B99-08932E300144Q34974033-D06336E6-873E-4BDC-AC1B-051F2BE376EBQ35067408-F39409B6-4EA5-4AFF-A369-58326B044F3AQ35676119-0DCF4BBC-4B28-4314-A589-4FF60FB39F08Q36559718-5323605B-5237-4D49-B719-35436F5BB653Q36577386-667E66D5-E494-42DB-8E53-CF1E12FE7803Q37439490-20421D1B-7071-442C-BFB5-7D6CB0893BEAQ37826365-7EF49EFE-577D-49FB-B350-BCBAA75F23A6Q38101678-FD91C3B2-789C-4EB0-BE4D-ED422FA871A2Q38239636-03DF9B6A-7B99-48E3-B37C-48AE43F4D38CQ39941840-EE2CD0F0-42F7-42F2-83EE-857440B0C3F3Q41788302-E3E02EFE-83ED-412C-97E8-94481650EB38Q45877842-930AA8EA-2918-4101-84E7-480520EDCFD7Q46872801-C57EC7C0-D838-4041-83DA-20A42BAA6DE7Q54192438-5BE4139B-96E4-4311-96AF-C0EE4BEA61D2
P2860
Reduction of arthritis severity in protease-activated receptor-deficient mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Reduction of arthritis severity in protease-activated receptor-deficient mice.
@en
Reduction of arthritis severity in protease-activated receptor-deficient mice.
@nl
type
label
Reduction of arthritis severity in protease-activated receptor-deficient mice.
@en
Reduction of arthritis severity in protease-activated receptor-deficient mice.
@nl
prefLabel
Reduction of arthritis severity in protease-activated receptor-deficient mice.
@en
Reduction of arthritis severity in protease-activated receptor-deficient mice.
@nl
P2093
P2860
P50
P356
P1476
Reduction of arthritis severity in protease-activated receptor-deficient mice
@en
P2093
Georgia Milenkovski
Peter Tipping
Yuan H Yang
P2860
P304
P356
10.1002/ART.21001
P577
2005-04-01T00:00:00Z